Mersana Therapeutics, Inc. (MRSN)
NASDAQ: MRSN · Real-Time Price · USD
0.3437
-0.0053 (-1.52%)
At close: May 30, 2025, 4:00 PM
0.3440
+0.0003 (0.09%)
After-hours: May 30, 2025, 7:49 PM EDT
Mersana Therapeutics Stock Forecast
MRSN's stock price has decreased by -85.37% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 4 professional analysts, the 12-month price target for Mersana Therapeutics stock ranges from a low of $3.00 to a high of $10. The average analyst price target of $5.75 forecasts a 1,572.97% increase in the stock price over the next year.
Price Target: $5.75 (+1,572.97%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Mersana Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 2 | 2 | 2 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 7 | 7 | 7 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Maintains $9 → $10 | Strong Buy | Maintains | $9 → $10 | +2,809.51% | May 16, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +1,354.76% | May 16, 2025 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Feb 6, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $6 → $5 | Strong Buy | Maintains | $6 → $5 | +1,354.76% | Aug 27, 2024 |
| Baird | Baird | Hold Maintains $4 → $3 | Hold | Maintains | $4 → $3 | +772.85% | Aug 14, 2024 |
Financial Forecast
Revenue This Year
30.44M
from 40.50M
Decreased by -24.83%
Revenue Next Year
25.18M
from 30.44M
Decreased by -17.29%
EPS This Year
-0.67
from -0.56
EPS Next Year
-0.62
from -0.67
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 55.7M | 44.9M | 43.6M | ||
| Avg | 30.4M | 25.2M | 20.9M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 37.4% | 47.6% | 73.1% | ||
| Avg | -24.8% | -17.3% | -16.9% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.34 | -0.14 | -0.61 | ||
| Avg | -0.67 | -0.62 | -0.78 | ||
| Low | -0.78 | -0.87 | -0.87 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.